Expression of Urokinase-type Plasminogen Activator Receptor and its Soluble Form in Type 2 Diabetic Kidney Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expression of Urokinase-type Plasminogen Activator Receptor and its Soluble Form in Type 2 Diabetic Kidney Disease

Published:2019-07 Issue:5 Volume:50 Page:249-256
ISSN:0188-4409
Container-title:Archives of Medical Research
language:en
Short-container-title:Archives of Medical Research

Author:

Zhou Yujing,Ren Jianmin,Li Peng,Ma Rong,Zhou Mengkun,Zhang Ningxin,Kong Xiangguo,Hu Zhao,Xiao Xiaoyan

Funder

Natural Science Foundation of Shandong Province

Key Research and Development Plan of Shandong Province

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. suPAR: the molecular crystal ball;Thuno;Dis Markers,2009

2. Biomarkers of kidney injury and klotho in patients with atherosclerotic renovascular disease;Park;Clin J Am Soc Nephrol,2015

3. Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression;Wilhelm;J Cell Physiol,1999

4. Shedding and cleavage of the urokinase receptor (uPAR): identification and characterization of uPAR fragments in vitro and in vivo;Sidenius;FEBS Lett,2000

5. Soluble urokinase plasminogen activator receptor measurements: influence of sample handling;Riisbro;Int J Biol Markers,2001

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factor XII signaling via uPAR-integrin β1 axis promotes tubular senescence in diabetic kidney disease;Nature Communications;2024-09-11

2. Soluble urokinase plasminogen activator receptor (suPAR) in children with obesity or type 1 diabetes as a marker of endothelial dysfunction: a cross-sectional study;European Journal of Pediatrics;2024-03-07

3. Albuminuria and Serum Tumor Necrosis Factor Receptor Levels in Patients with Type 2 Diabetes on SGLT2 Inhibitors: A Prospective Study;Diabetes Therapy;2023-10-26

4. Correlation Study between C-Reactive Protein and Renal Lesions in Patients with Type 2 Diabetes Mellitus;Advances in Clinical Medicine;2023

5. Involvement of Inflammasome Components in Kidney Disease;Antioxidants;2022-01-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3